PGEN ▲ +2.1% - Precigen, Inc. $PGEN PGEN - Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform Precigen received an FDA Platform Technology Designation for its AdenoVerse Platform, a recognition that could streamline future regulatory pathways for therapies built on this technology. The designation validates the platform's potential utility across multiple therapeutic applications, which likely contributed to the stock's 2.1% gain today. 21-SEP-2026 07:00 AM ET